Oxford Finance closed a $15 million senior secured term loan with Vedanta Biosciences, a clinical-stage biopharmaceutical company developing a new category of therapies for immune-mediated diseases based on defined bacterial consortia.
Selecta Biosciences entered into a debt financing facility for up to $35 million with Oxford Finance and Silicon Valley Bank. Selecta will use the financing to retire $12.6 million of existing debt, to advance its ImmTOR pipeline and for business development activities.
Oxford Finance closed a term loan and revolving line of credit to ReMed, a provider of rehab services to patients with post-acute acquired brain injuries. ReMed will use the proceeds for working capital purposes and to partially finance an acquisition.
KeyBank Specialty Finance Lending closed a $50 million revolving credit facility for the Oxford Finance Credit Fund I LP, a private debt fund managed by Oxford Finance.
Oxford Finance closed a $104.3 million senior secured credit facility to Epic Healthcare Staffing, a portfolio company of private equity firm Webster Equity Partners.
Syros Pharmaceuticals closed a $60 million senior secured loan facility with Oxford Finance, a specialty finance firm providing senior debt to life sciences and healthcare service companies.
Oxford Finance closed a senior credit facility for Impact, a provider of clinical, revenue cycle and information technology advisory services to the healthcare industry.
Oxford Finance closed a $87.5 million term loan and revolving line of credit to Tarrytown Expocare.
Oxford Finance closed a term loan for a portfolio company of Skyway Group that will be managed by Mission Health Communities. The funds will be used for the acquisition of 15 skilled nursing facilities in Kansas.
Oxford Finance closed a $25.5 million term loan and revolving line of credit to PhysicianOne Urgent Care, an operator of 18 urgent care centers in Connecticut, Massachusetts, and New York.